Decrease of miR-195 Promotes Chondrocytes Proliferation and Maintenance of Chondrogenic Phenotype via Targeting...

Area of Science:

• Biomedical Science
• Molecular Biology
• Regenerative Medicine

Background:

• Chronic cartilage lesions are characterized by slow chondrocyte growth and phenotype loss.
• The specific role and mechanism of microRNA-195 (miR-195) in these processes are not well understood.
• Fibroblast growth factor 18 (FGF-18) is crucial for cartilage homeostasis, but its regulation by miR-195 is unclear.

Purpose of the Study:

• To investigate the role of miR-195 in chondrocyte proliferation and chondrogenic phenotype maintenance.
• To determine if miR-195 regulates FGF-18 and its downstream signaling pathways.
• To explore the therapeutic potential of targeting the miR-195/FGF-18 axis for chronic cartilage lesions.

Main Methods:

• Analysis of miR-195 and FGF-18 expression in patient joint fluid and chondrocyte samples.
• Loss-of-function studies using miR-195 inhibitors in chondrocytes.
• Bioinformatic analysis and dual-luciferase reporter assays to confirm direct targeting of FGF-18 by miR-195.
• In vivo studies using an anterior cruciate ligament transection (ACLT) model in rats.

Main Results:

• miR-195 was upregulated and FGF-18 downregulated in chronic cartilage lesions.
• Downregulation of miR-195 promoted chondrocyte proliferation and expression of cartilage markers (Col2a1/aggrecan).
• miR-195 directly targets FGF-18, regulating chondrocyte function via the FGF-18 pathway.
• In vivo, miR-195 inhibition protected against cartilage damage in an ACLT model.

Conclusions:

• A decrease in miR-195 promotes chondrocyte proliferation and maintains chondrogenic phenotypes by targeting the FGF-18 pathway.
• The miR-195/FGF-18 axis represents a promising therapeutic target for treating chronic cartilage lesions.
• Targeting miR-195 offers a potential strategy for cartilage repair and regeneration.